Cancer Advisor

By The Medical Advisor Editorial Team | Last Updated: May 2026 Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Cancer treatment is highly individualized. Metabolic interventions can interact with chemotherapy, immunotherapy, or radiation and may cause harm if used improperly. Always consult your oncology team before adding any intervention. Evidence levels vary; many elements discussed remain investigational. Executive Summary Cancer is increasingly understood as more than a genetic disease. Dr. Thomas N. Seyfried , Professor of Biology at Boston College, and a growing body of metabolic oncology researchers propose that dysfunctional cellular energy production — centered on the mitochondria — is a defining and potentially modifiable axis of cancer biology. A 2026 large-scale population study published in Nature Communications demonstrated that machine learning-predicted insulin resistance was associated with increased risk of...

Introduction: The Promise and the Gap Metabolic therapy in oncology — encompassing ketogenic diets, caloric restriction, glucose-lowering drugs like metformin, and combinations thereof — has moved from fringe hypothesis to serious clinical inquiry over the past decade. Yet a fundamental question persists in both the research literature and the clinic: which patients actually respond? The answer is neither simple nor universal. Response to metabolic interventions appears to depend on tumor genetics, metabolic phenotype, immune context, and patient physiology. Understanding these variables is no longer optional for clinicians or researchers seeking to apply these approaches responsibly. This article reviews the current evidence on patient selection for metabolic therapy, identifies the biomarkers and tumor characteristics most associated with response, and highlights where the field still lacks clarity. What Is Metabolic Therapy in Cancer? Metabolic therapy refers to any intervention tha...

When navigating a cancer diagnosis, establishing the primary objective of a treatment plan is one of the most critical steps a medical team takes. Modern oncology utilizes a precise framework to categorize malignancies based on their responsiveness to systemic treatments like chemotherapy, targeted therapies, and radiation. Rather than viewing advanced or complex cancers through a single lens, clinical practice stratifies diseases into three distinct treatability tiers: curable , survival-extending (chronic) , and palliative . Credit: Cancer Care (2nd Edition) Metabolic oncology and its potential role in cancer treatment have sparked significant interest online. Through our research, we observed that the majority of available evidence remains preclinical, with a notable lack of large-scale published clinical trials. In many cases, adding metabolic therapy to standard cancer treatment may improve outcomes, such as faster tumor shrinkage or reductions in cancer biomarkers includi...

Medically Reviewed by: OneDayMD Editorial Team |  Last Updated: May 2026 Table of Contents Editor's Note Why This Matters: Evidence, and RCTs Introduction Fenbendazole Case Series Compilation (alphabetical) Breast Cancer Success Stories (123 cases — dedicated article) Brain Cancer (including Glioblastoma) (125 cases — dedicated article) Bladder Cancer Success Stories  (32 cases — dedicated article; see also #9 Kidney) Cervical Cancer (6 cases — dedicated article) Colorectal Cancer (including Appendix cancer) (80 cases — dedicated article) Esophageal and Stomach cancer (23 cases — dedicated article) Endometrial Cancer (11 cases — dedicated article) Head and Neck Cancer (16 cases — dedicated article) Kidney Cancer Case Series  (32 cases — dedicated article; see also #3 Bladder) Liver and Bile Duct Cancer (Hepato-biliary system) (8 cases) Lung Cancer (46 cases — dedicated article)) Leukemia (10 cases) Lymphoma (25 cases) Melanoma (refer to Skin Ca...